AMBUJACEM Ambuja Cements Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Construction MaterialsSmart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about AMBUJACEM
In the last completed session, Ambuja Cements Ltd. closed +0.00% with futures open interest moving -0.3%. Positioning is neutral — neither side is decisively adding or unwinding right now. The stock's option PCR sits at 0.44, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹435 sits 1.3% below the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Ambuja Cements Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Ambuja Cements Ltd. is best read as range-bound for now. The next scheduled earnings report is on 2026-07-28, with the consensus EPS estimate at ₹1.98667. Earnings days routinely override positioning signals — keep an eye on the calendar.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Basic Materials
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Broker Calls as reported · last 120 days
| Date | Brokerage | Call | Target | Source |
|---|---|---|---|---|
| 2026-07-17 | Bernstein | Upgrade · Outperform | — | NDTV Profit |
| 2026-07-14 | Bernstein | Upgrade · Outperform | — | NDTV Profit |
| 2026-07-13 | Bernstein | Upgrade · Outperform | — | NDTV Profit |
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-07-28 · spot 438 · EOD 2026-07-20
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 62%
Δ 0.80
θ -0.8
ν 0
|
410 | |
|
IV 49%
Δ 0.80
θ -0.7
ν 0
|
415 |
IV 37%
Δ -0.14
θ -0.3
ν 0
|
|
IV 34%
Δ 0.83
θ -0.4
ν 0
|
420 |
IV 37%
Δ -0.19
θ -0.4
ν 0
|
|
IV 35%
Δ 0.74
θ -0.6
ν 0
|
425 |
IV 36%
Δ -0.26
θ -0.5
ν 0
|
|
IV 37%
Δ 0.66
θ -0.6
ν 0
|
430 S |
IV 36%
Δ -0.34
θ -0.6
ν 0
|
|
IV 35%
Δ 0.57
θ -0.6
ν 0
|
435 MP |
IV 36%
Δ -0.43
θ -0.6
ν 0
|
|
IV 37%
Δ 0.48
θ -0.7
ν 0
|
440 |
IV 36%
Δ -0.52
θ -0.6
ν 0
|
|
IV 37%
Δ 0.40
θ -0.7
ν 0
|
445 R |
IV 37%
Δ -0.61
θ -0.6
ν 0
|
|
IV 38%
Δ 0.32
θ -0.6
ν 0
|
450 |
IV 35%
Δ -0.70
θ -0.5
ν 0
|
|
IV 38%
Δ 0.25
θ -0.5
ν 0
|
455 |
IV 74%
Δ -0.62
θ -1.2
ν 0
|
|
IV 40%
Δ 0.20
θ -0.5
ν 0
|
460 |
IV 41%
Δ -0.80
θ -0.4
ν 0
|
|
IV 40%
Δ 0.15
θ -0.4
ν 0
|
465 |
IV 56%
Δ -0.76
θ -0.7
ν 0
|
| 470 |
Chain Interpretation
Strategy Builder multi-leg payoff for AMBUJACEM options · 2026-07-28 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
AMBUJACEM — frequently asked questions
What is the Ambuja Cements Ltd. share price today?
AMBUJACEM is trading at ₹440.85 (+0.70% vs previous close), per the latest update on this page.
What is the P/E ratio of Ambuja Cements Ltd.?
AMBUJACEM (Ambuja Cements Ltd.) has a trailing twelve-month P/E ratio of 23.1.
What is the market cap of Ambuja Cements Ltd.?
AMBUJACEM has a market capitalisation of approximately ₹109,543 crore.
What is the ROE of Ambuja Cements Ltd.?
AMBUJACEM has a return on equity (ROE) of about 8.3%.
Is AMBUJACEM near its 52-week high?
AMBUJACEM is trading -29.9% from its 52-week high of ₹624.95 as of 2026-07-20.
What is the RSI of AMBUJACEM?
The 14-day RSI of AMBUJACEM is 54.6, which is considered neutral.
Is AMBUJACEM above its 200-day moving average?
AMBUJACEM is trading below its 200-DMA of ₹493.88 (-11.3% away).
What is the F&O buildup in AMBUJACEM?
The latest end-of-day derivatives data classifies AMBUJACEM as Neutral (bias: neutral), based on the day's combined price and open-interest change.
What is the max pain and PCR for AMBUJACEM options?
AMBUJACEM's option-chain max pain strike is ₹435 and its put-call ratio (OI) is 0.44, from the latest end-of-day option chain.
Are FIIs or big investors buying AMBUJACEM?
Strota tracks every bulk and block deal in AMBUJACEM with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.
What is the latest broker call on AMBUJACEM?
The most recent analyst call reported in the press is Bernstein: Upgrade · Outperform (2026-07-17). The Broker Calls section on this page lists reported calls from the last 120 days with links to the original reports.